NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) Combined with N-803 IL-15 Fusion Protein

World’s first combination of tumor-targeted, off-the-shelf PD-L1-targeted Natural Killer cells with IL-15 fusion protein (N-803) to induce immune system activation of both the NK and T-cells demonstrated complete response in second-line metastatic pancreatic cancer,...

38th Annual J.P. Morgan Healthcare Conference

38th Annual J.P. Morgan Healthcare ConferenceDATE: 01/14/2020TIME: 11:00 AM PSTLOCATION: Westin St. Francis in San Francisco, CA To download the presentation, please click the link below. Download Presentation (PDF) To access the event webcast, please click the link...